bluebird bio Ready to Rally on Regeneron Investment

BLUE and REGN are partnering on new cell therapies for cancer

Aug 6, 2018 at 9:16 AM
facebook twitter linkedin


Massachusetts-based biotech company bluebird bio (NASDAQ:BLUE) today announced a collaboration with Regeneron Pharmaceuticals (NASDAQ:REGN) to jointly develop new cell therapies for cancer. Under the terms of the partnership, Regeneron will invest $100 million in bluebird, or $238.10 per share -- 58.7% north of BLUE's Friday close at $150.

It hasn't been the best year for BLUE shares in 2018, as they've dropped 35.6% from their March 12 closing high of $233.05, and they enter today's trading down by nearly 16% year-to-date. In fact, BLUE's 14-day Relative Strength Index (RSI) was resting at a near-oversold 34 by the end of last week.

That said, the stock is up 4.7% ahead of the bell, bouncing from a recent pullback to its 320-day moving average. And on a year-over-year basis, the equity has advanced 60%.

But given the stock's more recent technical troubles, it's no surprise to find that options players are favoring puts over calls. Schaeffer's put/call open interest ratio (SOIR) of 1.00 registers in the 91st percentile of its annual range, as speculative players have rarely been more put-skewed in the past year. And the front-month gamma-weighted SOIR, which narrows the focus to near-the-money strikes in the August series, checks in at a top-heavy 2.25.

BLUE remains heavily shorted, as well, with short interest accounting for 7.8% of the stock's float. That supply of bearish bets represents 4.9 times the equity's average daily trading volume, and a capitulation by some of the weaker shorts in light of today's news could help fuel upside for the stock.

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners